Literature DB >> 8809471

Class II antigen processing: analysis of compartments and functions.

C V Harding1.   

Abstract

The endocytic and phagocytic pathways are composed of a series of vesicular or vacuolar organelles within the cytoplasm in which exogenous proteins or particles are processed. This processing includes catabolism of protein antigens by proteases that exist within endosomes, lysosomes, phagosomes, and phagolysosomes. Antigen processing produces peptides that bind to class II MHC (MHC-II) molecules, which also target to vesicular compartments. Multiple different vesicular compartments may contribute to antigen processing, although some compartments appear to be specialized in order to perform certain antigen processing functions. The relative levels of MHC-II molecules, processing enzymes, and other specialized molecules (e.g., HLA-DM) are among the variables that determine the relative contribution of different compartments. Recent studies have begun to identify specific compartments that mediate certain antigen processing functions, including the binding of immunogenic peptides to MHC-II molecules.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8809471     DOI: 10.1615/critrevimmunol.v16.i1.20

Source DB:  PubMed          Journal:  Crit Rev Immunol        ISSN: 1040-8401            Impact factor:   2.214


  10 in total

1.  Persistence of zinc-binding bacterial superantigens at the surface of antigen-presenting cells contributes to the extreme potency of these superantigens as T-cell activators.

Authors:  Dorothy D Pless; Gordon Ruthel; Emily K Reinke; Robert G Ulrich; Sina Bavari
Journal:  Infect Immun       Date:  2005-09       Impact factor: 3.441

2.  Class II MHC antigen presentation defect in neonatal monocytes is not correlated with decreased MHC-II expression.

Authors:  David H Canaday; Soma Chakravarti; Tarun Srivastava; Daniel J Tisch; Vinay K Cheruvu; Jamie Smialek; Clifford V Harding; Lakshmi Ramachandra
Journal:  Cell Immunol       Date:  2007-02-26       Impact factor: 4.868

3.  Alternative endogenous protein processing via an autophagy-dependent pathway compensates for Yersinia-mediated inhibition of endosomal major histocompatibility complex class II antigen presentation.

Authors:  Holger Rüssmann; Klaus Panthel; Brigitte Köhn; Stefan Jellbauer; Sebastian E Winter; Sara Garbom; Hans Wolf-Watz; Sigrid Hoffmann; Silke Grauling-Halama; Gernot Geginat
Journal:  Infect Immun       Date:  2010-09-27       Impact factor: 3.441

4.  Dendritic cell maturation and antigen presentation in the absence of invariant chain.

Authors:  P Rovere; V S Zimmermann; F Forquet; D Demandolx; J Trucy; P Ricciardi-Castagnoli; J Davoust
Journal:  Proc Natl Acad Sci U S A       Date:  1998-02-03       Impact factor: 11.205

5.  IgG keeps virulent Salmonella from evading dendritic cell uptake.

Authors:  Sebastián A Riquelme; Susan M Bueno; Alexis M Kalergis
Journal:  Immunology       Date:  2012-07       Impact factor: 7.397

6.  Enhanced delivery of exogenous peptides into the class I antigen processing and presentation pathway.

Authors:  Lolke De Haan; Arron R Hearn; A Jennifer Rivett; Timothy R Hirst
Journal:  Infect Immun       Date:  2002-06       Impact factor: 3.441

7.  Cytoplasmic processing is a prerequisite for presentation of an endogenous antigen by major histocompatibility complex class II proteins.

Authors:  J D Lich; J F Elliott; J S Blum
Journal:  J Exp Med       Date:  2000-05-01       Impact factor: 14.307

8.  Complex carbohydrates are not removed during processing of glycoproteins by dendritic cells: processing of tumor antigen MUC1 glycopeptides for presentation to major histocompatibility complex class II-restricted T cells.

Authors:  Anda M Vlad; Stefan Muller; Mare Cudic; Hans Paulsen; Laszlo Otvos; Franz-Georg Hanisch; Olivera J Finn
Journal:  J Exp Med       Date:  2002-12-02       Impact factor: 14.307

9.  STAT3 inhibitor Napabucasin abrogates MDSC immunosuppressive capacity and prolongs survival of melanoma-bearing mice.

Authors:  Rebekka Bitsch; Annina Kurzay; Feyza Özbay Kurt; Carolina De La Torre; Samantha Lasser; Alisa Lepper; Alina Siebenmorgen; Verena Müller; Peter Altevogt; Jochen Utikal; Viktor Umansky
Journal:  J Immunother Cancer       Date:  2022-03       Impact factor: 12.469

Review 10.  Proteolysis and antigen presentation by MHC class II molecules.

Authors:  Paula Wolf Bryant; Ana-Maria Lennon-Duménil; Edda Fiebiger; Cécile Lagaudrière-Gesbert; Hidde L Ploegh
Journal:  Adv Immunol       Date:  2002       Impact factor: 3.543

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.